Centene Corp. Hits New 52-Week High at $66.54, Showcasing Strong Growth

Centene Corp., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 66.54 on June 9, 2026. This achievement marks a notable recovery for the stock, especially considering its 52-week low of USD 25.08. Despite the recent uptick, Centene's one-year performance stands at -5.2%, contrasting sharply with the S&P 500's impressive gain of 22.99% over the same period. The company's market capitalization is approximately USD 16,287 million, categorizing it as a mid-cap stock. Financial metrics reveal a price-to-earnings (P/E) ratio of 25.00, indicating how the market values the company's earnings relative to its stock price. Additionally, Centene's return on equity is reported at 3.30%, while its price-to-book ratio stands at 0.82. The company currently does not offer a dividend yield, and its debt-to-equity ratio is noted at -0.14, reflecting its financial structure. This recent performance highlights Centene Corp.'s position within the healthcare sector as it navigates the complexities of the market.